ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival

Yang, Jing; Wu, Zixuan; Wu, Xiaoxi; Chen, Siya; Xia, Xinhua*; Zeng, Jianguo*广州中医药大学; 湖南农业大学
Frontiers in Oncology2022-12-22DOI: 10.3389/fonc.2022.1050288
6被引8阅读
引用收藏
分享

摘要

BackgroundStomach adenocarcinoma (STAD) arises from the mutations of stomach cells and has poor overall survival. Chemotherapy is commonly indicated for patients with stomach cancer following surgical resection. The most prevalent alteration that affects cancer growth is N6-methyladenosine methylation (m6A), although the possible function of m6A in STAD prognosis is not recognized. MethodThe research measured predictive FRGs in BLCA samples from the TCGA and GEO datasets. Data on the stemness indices (mRNAsi), gene mutations, copy number variations (CNV), tumor mutation burden (TMB), and corresponding clinical characteristics were obtained from TCGA and GEO. STAD from TCGA and GEO at 24 m6A was investigated. Lasso regression was used to construct the prediction model to assess the m6A prognostic signals in STAD. In addition, the correlation between m6a and immune infiltration in STAD patients was discussed using GSVA and ssGSEA analysis. Based on these genes, GO and KEGG analyses were performed to identify key biological functions and key pathways. ResultA significant relationship was discovered between numerous m6A clusters and the tumor immune microenvironment, as well as three m6A alteration patterns with different clinical outcomes. Furthermore, GSVA and ssGSEA showed that m6A clusters were significantly associated with immune infiltration in the STAD. The low-m6Ascore group had a lower immunotherapeutic response than the high-m6Ascore group. ICIs therapy was more effective in the group with a higher m6Ascore. Three writers (VIRMA, ZC3H13, and METTL3) showed significantly lower expression, whereas five authors (METTL14, METTL16, WTAP, RBM15, and RBM15B) showed considerably higher expression. Three readers (YTHDC2, YTHDF2, and LRPPRC) had higher levels of expression, whereas eleven readers (YTHDC1, YTHDF1, YTHDF3, HNRNPC, FMR1, HNRNPA2B1, IGFBP1, IGFBP2, IGFBP3, and RBMX) had lower levels. As can be observed, the various types of m6 encoders have varied ramifications for STAD control. ConclusionSTAD occurrence and progression are linked to m6A-genes. Corresponding prognostic models help forecast the prognosis of STAD patients. m6A-genes and associated immune cell infiltration in the tumor microenvironment (TME) may serve as potential therapeutic targets in STAD, which requires further trials. In addition, the m6a-related gene signature offers a viable alternative to predict bladder cancer, and these m6A-genes show a prospective research area for STAD targeted treatment in the future.

学科与关键词

关键词
stomach adenocarcinoma (STAD)M6Apredicting modelimmunitySNPCNV
相关
加载中…
  • N6-methylandenosine-related immune genes correlate with prognosis and immune landscapes in gastric cancer
    Huang, Yuancheng; Zou, Yushan; Tian, Yanhua; Yang, Zehong; Hou, Zhengkun; Li, Peiwu; Liu, Fengbin*; Ling, Jiasheng*; Wen, Yi*Frontiers in Oncology, 2022, 12: 1009881.
  • m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma
    Huang, Zhen-Dong; Lin, Lu-Lu; Liu, Zi-Zhen; Hu, Chao*; Gu, Hui-Yun*; Wei, Ren-Xiong*Frontiers in Immunology, 2021, 12: 765723.被引 7
  • N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients
    Zhang, Peiling; Liu, Guolong*; Lu, Lin*Frontiers in Cell and Developmental Biology, 2021, 9: 703629.被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-12-22
卷期
第 12 卷
页码
1050288
DOI
10.3389/fonc.2022.1050288
期刊等级
3区
成果收录
SCIE
资助标注
Hunan Province Traditional Chinese Medicine Research Program; First-class Discipline Project on Chinese Pharmacology of Hunan University of Chinese Medicine; [2021211]; [201803]

作者

  • Y

    Yang, Jing (第一作者)

    hunan agr univ · hunan univ chinese med

  • W

    Wu, Zixuan

    hunan univ chinese med

查看全部 6 位作者收起作者
  • W

    Wu, Xiaoxi

    2 · guangzhou univ chinese med

  • C

    Chen, Siya

    hunan univ chinese med

  • X

    Xia, Xinhua (通讯)

    hunan univ chinese med

  • Z

    Zeng, Jianguo (通讯)

    hunan agr univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417